Science News

SAN FRANCISCO--(BUSINESS WIRE)--On the occasion of the 44th J.P. Morgan Healthcare Conference in San Francisco, Bayer AG today unveiled the strategic focus for its Pharmaceuticals Division in 2026. Capitalizing on new launch momentum, the company will drive significant global regulatory expansions and market penetration across its pharmaceutical portfolio. High-value commercial products and an accelerating modality-rich pipeline across oncology, cardiology, neurology, and immunology have firmly...

SAN DIEGO--(BUSINESS WIRE)--Travere Therapeutics, Inc., (Nasdaq: TVTX) announced that today the U.S. Food and Drug Administration (FDA) has extended the review timeline of its supplemental New Drug Application (sNDA) for FILSPARI® (sparsentan) in focal segmental glomerulosclerosis (FSGS). The new Prescription Drug User Fee Act (PDUFA) target action date is April 13, 2026. The extension follows the recent submission of responses requested by the FDA to further characterize the clinical benefit o...

SAN FRANCISCO--(BUSINESS WIRE)--Animate Bio reports positive preclinical data showing two AI-designed peptides reduced lung fibrosis & inflammation, with the lead matching nintedanib...

COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has been selected as one of 10 companies awarded contracts under the Defense Microelectronics Activity’s (DMEA) Advanced Technology Support Program V (ATSP V). The 10-year, government-wide, multiple award Indefinite Delivery/Indefinite Delivery (IDIQ) contract vehicle has a ceiling of $25.35 billion, to rapidly provide engineering solutions for electronics and software problems. Under the contract, Battelle will deliver engineering development capabilit...

CAMBRIDGE, England & EDINBURGH, Scotland--(BUSINESS WIRE)--Axol Bioscience Ltd. (Axol), a leading provider of induced pluripotent stem cell (iPSC) technologies for drug discovery and disease research, today announced that it has secured $2.8 million (£2.1 million) in funding. The investment was led by US life sciences specialist BroadOak Capital Partners, with the company’s founding investor, the Roslin Foundation, also participating. The funding will accelerate Axol’s next phase of growth, sup...

ATLANTA--(BUSINESS WIRE)--Dr. Taz Bhatia, a leading expert in modernized holistic medicine, integrating traditional healing with contemporary medical advancements, has reimagined the future of health with the launch of hol+. This new functional medical home combines the best of eastern and western medicine to create a one stop shop for primary and consultative care, utilizing a holistic approach. hol+, founded by triple board-certified physician and integrative medicine pioneer Dr. Taz Bhatia,...

DENVER--(BUSINESS WIRE)--Lumivero acquires SharpCloud, expanding its decision portfolio with interactive data visualization software for enterprise project portfolios....

NASHVILLE, Tenn.--(BUSINESS WIRE)--Joi + Blokes, a national precision medicine and telehealth platform, announced the publication of a peer-reviewed clinical study in collaboration with Brigham Young University (BYU) that evaluates the outcomes of its proprietary, biomarker-guided precision medicine protocols. The study was published in the scientific journal Life and assesses changes in key inflammatory biomarkers among adults aged 40 to 69. “This study evaluates a precision medicine framework...

NEW YORK--(BUSINESS WIRE)--Blue Matter is pleased to announce that it has established a practice area dedicated to serving clients in biopharmaceutical Research & Development (R&D). The practice is led by Tara Austraat-Churik, a Partner who joined the firm in September 2025. Tara Austraat-Churik has been serving life science clients for more than 20 years. Her areas of expertise include strategy development and implementation, operating model and organizational design, and process optim...

RALEIGH, N.C.--(BUSINESS WIRE)--Univo IRB, today’s fastest-growing central institutional review board (IRB), announced it has successfully completed a routine inspection by the U.S. Food and Drug Administration (FDA) with no findings. The outcome exemplifies Univo IRB’s unwavering commitment to protecting research participants and upholding the highest standards of ethical and regulatory oversight in clinical research. “This inspection result reflects our expertise, diligence, and continued foc...